ArticleScientific reports2025
Textbook outcome of gastric cancer surgery and lymph node evaluation as its parameter to improve long-term survival.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Impact of Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) on Survival Following Surgery for Esophagogastric Cancer: A Systematic Review and Meta-analysis.Annals of surgical oncology · 2026Review
- Validation of Textbook Outcome in Gastric Surgery (TOGS) for Primary Gastric Cancer in an Eastern High-Volume Center.Annals of surgical oncology · 2026Article
- ASO Author Reflections: Need for a Textbook Outcome in Gastric Surgery (TOGS) Specific for Gastric Cancer.Annals of surgical oncology · 2026Article
- Minimally Invasive Surgery in Gastric Cancer.Cancers · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The textbook outcome (TO) is a short-term outcome that integrates postoperative outcomes to evaluate the quality of surgery. In gastric cancer surgery, most TO data have been reported from Western countries. We aimed to analyze TO in Korea, where gastric cancer is prevalent and evaluate its effect on long-term survival. Based on the parameters defined by the Dutch Upper Gastrointestinal Cancer Audit (DUCA), we evaluated the TO, 5-year overall survival (OS), and independent prognostic factors stratified according to the TNM stage. The TO was achieved in 74.6% patients. Significant differences were observed in the 5-year OS rate between groups achieving TO and non-TO groups regardless of stage. The TO and ≥ 30 retrieved lymph nodes was an independent prognostic factor in patients with stage II/III tumors. The median number of retrieved lymph nodes required for D2 dissection increased depending on the tumor stage, from 38 in stage IA, whereas in distal and total gastrectomy D2 lymph node dissection was 44 and 55 in stages II and III, respectively. Therefore, evaluation of more than 30 lymph nodes should be considered to achieve optimal radical gastric cancer surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.